Ryan Bethencourt

CEO, SciRouter.ai | Consumer Health and Therapeutics Across Species

📍 San Francisco Bay Area, United States🔄 Updated September 2026💼 5 investments📅 13 years investing🗓 Last invested Oct 2020𝕏 @upgrade_to_unlock
VC🌍 United States
5
Total investments
3
Early stage
0
Mid stage
0
Late stage
13y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Oct 2020
Provectus Algae is a biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics. Importantly, Provectus Algae uses photosynthetic bioprocesses to transform light and carbon dioxide into critical bioproducts. Provectus Algae’s end-to-end biomanufacturing platform, powered by its Precision Photosynthesis™ technology, has far-reaching applications in a variety of industries, including food & beverage, agriculture, aquaculture, cosmetics & personal care, pharmaceuticals, and beyond. Microalgae biotechnology holds tremendous industrial potential thanks to microalgae’s impressive biochemical diversity, sophisticated biosynthesis machinery, and rapid growth rates. Photosynthetic microalgae species also provide the life science community with a powerful mechanism for reducing carbon footprint and improving sustainability. Provectus Algae built its biomanufacturing platform to take microalgae-based products from discovery to large-scale production, actualizing the full potential of microalgae biotechnology. We have brought together the combined strengths of our talented multidisciplinary team to rapidly build scalable microalgae production systems and source high-value compounds for our partners. Provectus Algae enables these groundbreaking capabilities with a well-balanced fusion of innovative proprietary technology and a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of our commercial partners. With Provectus Algae our partners enjoy: 1). Rapid Speed to Market Through End-to-End Supply Solutions 2). Environmentally Sustainable Biomanufacturing 3). Novel Natural and Synthetic Biology Products from Algae Start making your molecules using light and CO2 today!
Board Member
Aug 2020
Tiamat is developing a plant molecular farming technology to manufacture affordable high-value proteins to enable the next generation of technologies in Food and Pharma. Our unique technology allows us superior flexibility with an affordable production system and a scale-up. To provide high-value biomolecules at a fraction of their cost.
Board Member
Jul 2020
Jellatech is a B2B biotech business based in Raleigh, NC. Jellatech is producing high quality, pure, animal-free collagen and gelatin. Founded by a group of innovators, dreamers, entrepreneurs and scientists, Jellatech is eliminating the dependency on animals, to make better ingredient products - starting with collagen and gelatin. The collagen and gelatin industry is an industry that is based on the boiling of animal skin & bones and bits & pieces. Despite being on the back of animal carcasses and meat-industry byproducts, it’s a 3.5 billion dollar market with a 9% compound annual growth rate.
Board Member and Co-Founder
Jun 2013
We are building a new community lab for the East Bay, focused on DIY biology and citizen science. A place to explore, learn, work on fun projects, tinker with biology and other sciences. Open to biotech professionals, scientists, and citizen scientists of all stripes. Be part of our community of creative thinkers, hackers and mad scientists!
Experience · 10 entries
All (10)
Investments (4)
Founder (3)
Board (3)
2020
Board Member
Oct 2020
Provectus Algae is a biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics. Importantly, Provectus Algae uses photosynthetic bioprocesses to transform light and carbon dioxide into critical bioproducts. Provectus Algae’s end-to-end biomanufacturing platform, powered by its Precision Photosynthesis™ technology, has far-reaching applications in a variety of industries, including food & beverage, agriculture, aquaculture, cosmetics & personal care, pharmaceuticals, and beyond. Microalgae biotechnology holds tremendous industrial potential thanks to microalgae’s impressive biochemical diversity, sophisticated biosynthesis machinery, and rapid growth rates. Photosynthetic microalgae species also provide the life science community with a powerful mechanism for reducing carbon footprint and improving sustainability. Provectus Algae built its biomanufacturing platform to take microalgae-based products from discovery to large-scale production, actualizing the full potential of microalgae biotechnology. We have brought together the combined strengths of our talented multidisciplinary team to rapidly build scalable microalgae production systems and source high-value compounds for our partners. Provectus Algae enables these groundbreaking capabilities with a well-balanced fusion of innovative proprietary technology and a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of our commercial partners. With Provectus Algae our partners enjoy: 1). Rapid Speed to Market Through End-to-End Supply Solutions 2). Environmentally Sustainable Biomanufacturing 3). Novel Natural and Synthetic Biology Products from Algae Start making your molecules using light and CO2 today!
Managing Partner
Sep 2020
Our mission is to support founders developing sustainable food products and scaling profitable companies in the global $12 Trillion food and grocery retail market. We back early stage founders building leading food companies that are:
 • Plant-based • Cell-based • Recombinant SFV will not invest in any companies involved in animal agriculture.
Board Member
Aug 2020
Tiamat is developing a plant molecular farming technology to manufacture affordable high-value proteins to enable the next generation of technologies in Food and Pharma. Our unique technology allows us superior flexibility with an affordable production system and a scale-up. To provide high-value biomolecules at a fraction of their cost.
Board Member
Jul 2020
Jellatech is a B2B biotech business based in Raleigh, NC. Jellatech is producing high quality, pure, animal-free collagen and gelatin. Founded by a group of innovators, dreamers, entrepreneurs and scientists, Jellatech is eliminating the dependency on animals, to make better ingredient products - starting with collagen and gelatin. The collagen and gelatin industry is an industry that is based on the boiling of animal skin & bones and bits & pieces. Despite being on the back of animal carcasses and meat-industry byproducts, it’s a 3.5 billion dollar market with a 9% compound annual growth rate.
2017
Partner
Nov 2017
BABEL Ventures is leading the charge in early-stage consumer biotech investments. As the first VC check in many of our portfolio companies, we’ve seen diverse successes, from companies going public to returns as high as 40x - a true testament to our bold ethos and unwavering belief in groundbreaking ideas. Since our launch in 2017, we’ve remained steadfast in our commitment to empowering visionary entrepreneurs who are not only driving innovation but also shaping a more sustainable future.
Show all 10 entries ↓
Investment activity
2013–2020 · 5 investments
2013220203
Recent (last 2 years)Earlier